Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Infertility Drugs Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Gonadotropins
  • 1.4.3 Anti-Estrogens
• 1.5 Market by Application
  • 1.5.1 Global Infertility Drugs Market Share by Application (2014-2025)
  • 1.5.2 Male
  • 1.5.3 Female
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Infertility Drugs Market Size
• 2.2 Infertility Drugs Growth Trends by Regions
  • 2.2.1 Infertility Drugs Market Size by Regions (2014-2025)
  • 2.2.2 Infertility Drugs Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Infertility Drugs Market Size by Manufacturers
  • 3.1.1 Global Infertility Drugs Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Infertility Drugs Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Infertility Drugs Market Concentration Ratio (CR5 and HHI)
• 3.2 Infertility Drugs Key Players Head office and Area Served
• 3.3 Key Players Infertility Drugs Product/Solution/Service
• 3.4 Date of Enter into Infertility Drugs Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Infertility Drugs Market Size by Type (2014-2019)
• 4.2 Global Infertility Drugs Market Size by Application (2014-2019)

5 United States

• 5.1 United States Infertility Drugs Market Size (2014-2019)
• 5.2 Infertility Drugs Key Players in United States
• 5.3 United States Infertility Drugs Market Size by Type
• 5.4 United States Infertility Drugs Market Size by Application

6 Europe

• 6.1 Europe Infertility Drugs Market Size (2014-2019)
• 6.2 Infertility Drugs Key Players in Europe
• 6.3 Europe Infertility Drugs Market Size by Type
• 6.4 Europe Infertility Drugs Market Size by Application

7 China

• 7.1 China Infertility Drugs Market Size (2014-2019)
• 7.2 Infertility Drugs Key Players in China
• 7.3 China Infertility Drugs Market Size by Type
• 7.4 China Infertility Drugs Market Size by Application

8 Japan

• 8.1 Japan Infertility Drugs Market Size (2014-2019)
• 8.2 Infertility Drugs Key Players in Japan
• 8.3 Japan Infertility Drugs Market Size by Type
• 8.4 Japan Infertility Drugs Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Infertility Drugs Market Size (2014-2019)
• 9.2 Infertility Drugs Key Players in Southeast Asia
• 9.3 Southeast Asia Infertility Drugs Market Size by Type
• 9.4 Southeast Asia Infertility Drugs Market Size by Application

10 India

• 10.1 India Infertility Drugs Market Size (2014-2019)
• 10.2 Infertility Drugs Key Players in India
• 10.3 India Infertility Drugs Market Size by Type
• 10.4 India Infertility Drugs Market Size by Application

11 Central & South America

• 11.1 Central & South America Infertility Drugs Market Size (2014-2019)
• 11.2 Infertility Drugs Key Players in Central & South America
• 11.3 Central & South America Infertility Drugs Market Size by Type
• 11.4 Central & South America Infertility Drugs Market Size by Application

12 International Players Profiles

• 12.1 Merck
  • 12.1.1 Merck Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Infertility Drugs Introduction
  • 12.1.4 Merck Revenue in Infertility Drugs Business (2014-2019)
  • 12.1.5 Merck Recent Development
• 12.2 Ferring
  • 12.2.1 Ferring Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Infertility Drugs Introduction
  • 12.2.4 Ferring Revenue in Infertility Drugs Business (2014-2019)
  • 12.2.5 Ferring Recent Development
• 12.3 MSD
  • 12.3.1 MSD Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Infertility Drugs Introduction
  • 12.3.4 MSD Revenue in Infertility Drugs Business (2014-2019)
  • 12.3.5 MSD Recent Development
• 12.4 LIVZON
  • 12.4.1 LIVZON Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Infertility Drugs Introduction
  • 12.4.4 LIVZON Revenue in Infertility Drugs Business (2014-2019)
  • 12.4.5 LIVZON Recent Development
• 12.5 Abbott
  • 12.5.1 Abbott Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Infertility Drugs Introduction
  • 12.5.4 Abbott Revenue in Infertility Drugs Business (2014-2019)
  • 12.5.5 Abbott Recent Development
• 12.6 Bayer Zydus Pharma
  • 12.6.1 Bayer Zydus Pharma Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Infertility Drugs Introduction
  • 12.6.4 Bayer Zydus Pharma Revenue in Infertility Drugs Business (2014-2019)
  • 12.6.5 Bayer Zydus Pharma Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
Market competition is not intense. Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
North America is the largest consumption place, with a consumption market share nearly 44% in 2017. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
Infertility Drugs is widely used for males and females. The most proportion of Infertility Drugs is used for females, and the revenue in 2017 is 89%.
In 2018, the global Infertility Drugs market size was 4120 million US$ and it is expected to reach 5960 million US$ by the end of 2025, with a CAGR of 5.4% during 2019-2025.

This report focuses on the global Infertility Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infertility Drugs development in United States, Europe and China.

The key players covered in this study
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
...

Market segment by Type, the product can be split into
Gonadotropins
Anti-Estrogens

Market segment by Application, split into
Male
Female

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Infertility Drugs status, future forecast, growth opportunity, key market and key players.
To present the Infertility Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Infertility Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.